Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer’s Disease

Abstract

Bapineuzumab produced an increase in ventricular volume compared with placebo. Etiology for this increase is unclear but may be related to amyloid-β clearance or its consequences.